Laddar...
Antibody–Drug Conjugates for Cancer Therapy
Antibody–drug conjugates (ADCs) take advantage of the specificity of a monoclonal antibody to deliver a linked cytotoxic agent directly into a tumour cell. The development of these compounds provides exciting opportunities for improvements in patient care. Here, we review the key issues impacting on...
Sparad:
I publikationen: | Biomedicines |
---|---|
Huvudupphovsmän: | , , , , |
Materialtyp: | Artigo |
Språk: | Inglês |
Publicerad: |
MDPI
2016
|
Ämnen: | |
Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5344263/ https://ncbi.nlm.nih.gov/pubmed/28536381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines4030014 |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|